B+L issues voluntary recall of certain IOLs in enVista platform
Products

B+L issues voluntary recall of certain IOLs in enVista platform

Recall follows an increase in reports of toxic anterior segment syndrome connected to implants of the enVista Aspire, Envy, and other monofocal IOLs.
Alcon voluntarily recalls Systane Lubricant Eye Drops Ultra PF
Products

Alcon voluntarily recalls Systane Lubricant Eye Drops Ultra PF

Late last month, the FDA reported a potential risk for fungal contamination associated with one lot of the preservative-free eye drops.
Voluntary recall issued for eye ointments due to lack of sterility
Products

Voluntary recall issued for eye ointments due to lack of sterility

Four products from an India-based manufacturer were being distributed across the U.S. via CVS and Walmart.
Initial FDA inspection findings of recalled eye drops manufacturer indicate 14 problems
Products

Initial FDA inspection findings of recalled eye drops manufacturer indicate 14 problems

Agency reports unsanitary facility conditions and omitted/falsified contamination and sterility test results, among other violations. 
Pine Pharmaceuticals issues voluntary recall of ocular products
Products

Pine Pharmaceuticals issues voluntary recall of ocular products

Issued earlier this month, the notification includes Avastin (bevacizumab).
CooperVision recalls Biofinity sphere CLs in Singapore
Products

CooperVision recalls Biofinity sphere CLs in Singapore

Specific lots of monthly disposable lenses may contain foreign particles.
Lawsuits follow nationwide recall of eye drop products
Legal

Lawsuits follow nationwide recall of eye drop products

Over 10 cases are pending in federal courts since the initial recall in January 2023.
CDC reports new fatalities, vision loss in eye drop recall
Products

CDC reports new fatalities, vision loss in eye drop recall

Latest update includes additional patient cases and vision loss in a growing number of states.
Akorn Pharma recalls 70+ drugs from the US market
Products

Akorn Pharma recalls 70+ drugs from the US market

Company has ceased operations and shut down all facilities after filing for Chapter 7 bankruptcy in February 2023. 
Contamination issues reported at recalled eye products manufacturer
Legal

Contamination issues reported at recalled eye products manufacturer

FDA officials uncover procedures lacking sterility measures, according to a preliminary report of the investigation.
Death toll rises in artificial tears recall
Products

Death toll rises in artificial tears recall

CDC reports two more patients have died due to infection from EzriCare Artificial Tears, among other products.
Nationwide recall issued for two more eye drop products
Products

Nationwide recall issued for two more eye drop products

Apotex Corp. and Pharmedica USA announce voluntary recalls; advise customers to cease use immediately.
FDA extends recall to Delsam Pharma's Artificial Eye Ointment
Products

FDA extends recall to Delsam Pharma's Artificial Eye Ointment

Latest recall follows CDC recommendation to stop use of EzriCare and Delsam Pharma Artificial Tears earlier this month.
Class action lawsuit filed against EzriCare over artificial tears
Legal

Class action lawsuit filed against EzriCare over artificial tears

Latest filing alleges the company and other defendants, including Walgreens, violated federal regulations in distributing and selling contaminated products.
CDC identifies source of multistate bacteria outbreak due to artificial tears
Products

CDC identifies source of multistate bacteria outbreak due to artificial tears

Federal, state, and local investigation uncovers origination of nationwide infections and death.
Regener-Eyes launches new preservative-free bottles with backflow prevention
Products

Regener-Eyes launches new preservative-free bottles with backflow prevention

Company initiates voluntary recall for older bottles of Regener-Eyes Professional Strength and LITE products.
Genentech is reintroducing SUSVIMO implant for wet AMD in the US
Products

Genentech is reintroducing SUSVIMO implant for wet AMD in the US

Originally FDA approved in 2021, the ocular implant was voluntarily recalled in 2022.
FDA issues new warnings and guidance on OTC eye drops
Products

FDA issues new warnings and guidance on OTC eye drops

Agency updates consumer tips and recommendations after a busy year of product recalls and warnings.
Top 10 Glance stories of 2023
Events

Top 10 Glance stories of 2023

FDA approvals and eye drop recalls … find out which news was most trending this year.
FDA warns against use of 27 eye drops from major brands
Products

FDA warns against use of 27 eye drops from major brands

Yet another nationwide recall is in effect, this time hitting Walmart, CVS, Target, and other retail brands.